Archives of Endocrinology and Metabolism (Jun 2024)

Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases

  • Maria Julia Morguetti,
  • Precil Diego Miranda de Menezes Neves,
  • Ilana Korkes,
  • Wallace Stwart Carvalho Padilha,
  • Lectícia Barbosa Jorge,
  • Andreia Watanabe,
  • Elieser Hitoshi Watanabe,
  • Denise Maria Avancini Costa Malheiros,
  • Irene de Lourdes Noronha,
  • Sergio Atala Dib,
  • Luiz Fernando Onuchic,
  • Regina S. Moisés

DOI
https://doi.org/10.20945/2359-4292-2023-0204
Journal volume & issue
Vol. 68

Abstract

Read online

SUMMARY Lipodystrophies are characterized by complete or selective loss of adipose tissue and can be acquired or inherited. Familial partial lipodystrophy (FPLD) is a hereditary lipodystrophy commonly caused by mutations in the LMNA gene. Herein, we report two cases of FPLD associated with podocytopathies. Patient 1 was diagnosed with FPLD associated with the heterozygous p.Arg482Trp variant in LMNA and had normal glucose tolerance and hyperinsulinemia. During follow-up, she developed nephrotic-range proteinuria. Renal biopsy was consistent with minimal change disease. Patient 2 was diagnosed with FPLD associated with a de novo heterozygous p.Arg349Trp variant in LMNA. Microalbuminuria progressed to macroalbuminuria within 6 years and to nephrotic range proteinuria in the last year. He remained without diabetes and with hyperinsulinemia. Renal biopsy revealed focal segmental glomerulosclerosis not otherwise specified. This report provides further evidence of variable features of lipodystrophy associated with LMNA variants and the importance of long-term follow-up with evaluation of kidney dysfunction.